论文信息 - A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - 字舞流文

A Phase 1b Study Evaluating the Safety, Tolerability, and Immunogenicity of CMB305, a Lentiviral-Based Prime-Boost Vaccine Regimen, in Patients with Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1

Robin L. Jones | P. Hwu | Hailing Lu | S. Kim-Schulze | K. Tuballes | S. Gnjatic | K. Sankhala | J. T. ter Meulen | M. Block | S. Pollack | K. Do | S. Chawla | A. Yakovich | N. Somaiah | Joseph W. Kim | Michael M. Chen | Mahlet Yishak | R. Kenney | C. Bohac | M. Druta | J. Morris | J. Morris